- Home
- Navigating Perimenopause
Navigating Perimenopause: Symptoms, Treatment, And Controversies
Introduction
Perimenopause is the time before menopause when your body starts changing, often bringing a range of physical and emotional symptoms that can disrupt daily life. From weight gain to hot flashes to mood swings, these changes can be challenging, but effective treatments are available to restore balance and vitality.
At MD Total Wellness in Brea, CA, we specialize in personalized hormone therapy to help women thrive during this phase of life. Led by Allison Mollet, PA-C, a certified menopause provider (MSCP), our team is dedicated to guiding you through perimenopause with expert care.
Understanding Perimenopause
Perimenopause is the period when a woman’s body transitions toward menopause, typically beginning in the mid-30s to late 40s and lasting 7-10 years. It is characterized by fluctuating hormone levels, including estrogen, progesterone, and testosterone, as ovarian function declines. The first symptom is often irregular menstrual cycles, which may become shorter, longer, or unpredictable. Other symptoms include:
- Cognitive changes, like brain fog, memory lapses or difficulty concentrating
- Weight gain or changes in body composition
- Sleep disturbances
- Mood changes, such as irritability or anxiety
- Hot flashes and night sweats
- Fatigue and low energy
- Vaginal dryness and reduced libido
- Heart palpitations
- Joint and body pain
Subtle symptoms, such as joint pain or mild mood shifts, may go unnoticed but can significantly impact quality of life. These symptoms, even mild ones, can affect your daily life, but they don’t have to.
Bioidentical Hormone Therapy: The Gold Standard
Bioidentical hormone therapy (BHT) is the most effective treatment for managing perimenopause symptoms. BHT uses hormones identical to those produced by the body, including estrogen, progesterone, and testosterone, to restore balance and alleviate discomfort. Treatment is tailored to each woman’s needs, addressing specific symptoms and optimizing overall health.
Bioidentical hormone therapy (BHT) is the most effective treatment for managing perimenopause symptoms. BHT uses hormones identical to those produced by the body, including estrogen, progesterone, and testosterone, to restore balance and alleviate discomfort. Treatment is tailored to each woman’s needs, addressing specific symptoms and optimizing overall health.
Benefits of Hormone Therapy
Hormone therapy offers transformative benefits for women in perimenopause, addressing both immediate symptoms and long-term health:
1. Estrogen and Progesterone::
- These hormones relieve hot flashes, night sweats, and vaginal dryness while improving sleep and mood stability. Progesterone also protects the uterine lining, reducing the risk of endometrial hyperplasia.
2. Testosterone:
- Often underutilized, testosterone enhances libido, energy, muscle strength, and cognitive function.
3. Symptom Relief:
- BHT significantly reduces perimenopause symptoms, improving quality of life and emotional well-being.
4. Long-Term Health Benefits:
- When started within 10 years of menopause, BHT is associated with reduced risks of heart disease, osteoporosis, and dementia, as well as increased lifespan. The ELITE trial showed that early hormone therapy supports cardiovascular health.
5. Anti-Aging Effects:
- BHT promotes healthier skin, hair, and sexual function, while supporting brain health and vitality.
Treatment Options
BHRT is delivered in various forms, customized to individual needs:
1. Estrogen:
- Available as topical creams, patches, vaginal rings, injections, or pellets. Oral estrogen is generally avoided because it carries a higher risk of blood clots.
2. Progesterone:
- Typically administered orally to ensure endometrial protection.
3. Testosterone:
- Delivered via topical gels, vaginal creams, injections, or pellets. Oral testosterone is generally avoided.
Addressing Controversies
Hormone therapy faced scrutiny after the 2002 Women’s Health Initiative (WHI) study linked synthetic hormones, particularly progestins, to a small increased risk of breast cancer. However, the absolute risk was low, and subsequent research clarified that bioidentical hormones, such as estradiol and micronized progesterone, do not carry the same risks . The WHI’s findings led to a sharp decline in hormone therapy use, but recent evidence supports BHT’s safety and benefits, especially when initiated within 10 years of menopause . Studies also suggest that continuing BHT beyond the traditional “shortest time possible” recommendation can provide ongoing benefits, challenging outdated guidelines . Unfortunately, the healthcare system often prioritizes patented medications over bioidentical hormones, which cannot be patented, limiting their mainstream adoption.
Challenges in Hormone Therapy
Women’s hormone biology is complex, and effective treatment requires a personalized approach. Finding the optimal combination and dosage of estrogen, progesterone, and testosterone—often called the “hormone footprint”—takes time and expertise. Successful therapy depends on a provider’s ability to listen, adjust, and fine-tune treatment to address individual symptoms and health goals. This process demands patience and collaboration between patient and provider.
MD Total Wellness: Expert Care for Perimenopause
At MD Total Wellness in Brea, CA, we provide personalized hormone therapy tailored to each woman’s unique needs. Our board-certified providers, led by Allison Mollet, PA-C, MSCP, a certified menopause provider through the Menopause Society, offer specialized expertise in managing perimenopause. PA Mollet’s training and experience ensures high-quality, evidence-based care to help you feel your best. Our services include:
Customized Treatment Plans:
- Comprehensive evaluations to create individualized BHT regimens.
Ongoing Support:
- Regular follow-ups and lab monitoring to optimize therapy.
Convenient Care:
- In-office consultations and medication dispensed from the office or delivered to your door for a seamless experience.
Start Your Journey Today
Don’t let perimenopause symptoms hold you back. Schedule a comprehensive consultation and evaluation with Allison Mollet, PA-C, MSCP, at MD Total Wellness in Brea, CA. Take the first step toward symptom relief and long-term health.
Contact us at (714) 671-2005 or visit our website to book your free consultation.
Bibliography
- 1. Avis, N. E., et al. (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine, 175(4), 531–539.
- 2. Bolour, S., & Braunstein, G. D. (2005). Testosterone therapy in women: A review. International Journal of Impotence Research, 17(5), 399–408.
- 3. Canonico, M., et al. (2008). Hormone therapy and venous thromboembolism among postmenopausal women. Circulation, 117(6), 840–856.
- 4. Davis, S. R., et al. (2015). Testosterone for low libido in postmenopausal women not taking estrogen. New England Journal of Medicine, 359(19), 2005–2017.
- 5. Files, J. A., et al. (2011). Bioidentical hormone therapy. Mayo Clinic Proceedings, 86(7), 673–680.
- 6. Fournier, A., et al. (2008). Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. International Journal of Cancer, 122(7), 1618–1623.
- 7. Fournier, A., et al. (2009). Unequal risks for breast cancer associated with different hormone replacement therapies. Journal of Clinical Oncology, 27(18), 3115–3120.
- 8. Harlow, S. D., et al. (2012). Executive summary of the Stages of Reproductive Aging Workshop + 10. Menopause, 19(4), 387–395.
- 9. Hodis, H. N., et al. (2016). Vascular effects of early versus late postmenopausal treatment with estradiol. New England Journal of Medicine, 374(13), 1221–1231.
- 10. Lobo, R. A., et al. (2018). Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause. Atherosclerosis, 254, 282–290.
- 11. Manson, J. E., et al. (2013). Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA, 310(13), 1353–1368.
- 12. Rossouw, J. E., et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 288(3), 321–333.
- 13. Santen, R. J., et al. (2010). Postmenopausal hormone therapy: An Endocrine Society scientific statement. Journal of Clinical Endocrinology & Metabolism, 95(7_supplement_1), s1–s66.
- 14. Santoro, N. (2016). Perimenopause: From research to practice. Journal of Women’s Health, 25(4), 332–339.
- 15. Shifren, J. L., & Schiff, I. (2010). Role of hormone therapy in the management of menopause. Obstetrics & Gynecology, 115(4), 839–855.
Schedule Your Consultation
Work with a board-certified clinician to build a personalized plan.